View ValuationEvonik Industries 향후 성장Future 기준 점검 2/6Evonik Industries (는) 각각 연간 17.2% 및 2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 17.5% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 8.8% 로 예상됩니다.핵심 정보17.2%이익 성장률17.51%EPS 성장률Chemicals 이익 성장42.1%매출 성장률2.0%향후 자기자본이익률8.80%애널리스트 커버리지Good마지막 업데이트22 Apr 2026최근 향후 성장 업데이트공지 • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.공지 • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).모든 업데이트 보기Recent updates공지 • Apr 17Evonik Industries AG, Annual General Meeting, Jun 03, 2026Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time.공지 • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.공지 • Nov 06+ 2 more updatesEvonik Industries AG to Report Q1, 2026 Results on May 08, 2026Evonik Industries AG announced that they will report Q1, 2026 results on May 08, 2026공지 • Oct 06Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026공지 • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.공지 • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.Reported Earnings • Nov 07Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: €0.48 (up from €0.21 loss in 3Q 2023). Revenue: €3.83b (up 1.6% from 3Q 2023). Net income: €223.0m (up €319.0m from 3Q 2023). Profit margin: 5.8% (up from net loss in 3Q 2023). Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.공지 • Sep 20Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025Evonik Industries AG announced that they will report Q1, 2025 results on May 12, 2025공지 • Sep 04+ 1 more updateEvonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025Evonik Industries AG announced that they will report Q2, 2025 results on Aug 01, 2025Reported Earnings • Aug 02Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023)Second quarter 2024 results: €0.01 loss per share (improved from €0.58 loss in 2Q 2023). Revenue: €3.93b (up 1.1% from 2Q 2023). Net loss: €5.00m (loss narrowed 98% from 2Q 2023). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.Upcoming Dividend • May 29Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.1%).Reported Earnings • May 09First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023)First quarter 2024 results: EPS: €0.33 (up from €0.10 in 1Q 2023). Revenue: €3.80b (down 5.2% from 1Q 2023). Net income: €156.0m (up 232% from 1Q 2023). Profit margin: 4.1% (up from 1.2% in 1Q 2023). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance.공지 • Apr 20+ 1 more updateEvonik Industries AG, Annual General Meeting, May 28, 2025Evonik Industries AG, Annual General Meeting, May 28, 2025.Reported Earnings • Mar 05Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: €1.00 loss per share (down from €1.16 profit in FY 2022). Revenue: €15.3b (down 17% from FY 2022). Net loss: €465.0m (down 186% from profit in FY 2022). Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) also missed analyst estimates by 42%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.공지 • Mar 05International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik.International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik on March 4, 2024. The business to be sold generated sales of €892 million in 2023, with adjusted EBITDA in the mid double-digit million euro range. The final transfer of the business is planned for mid-2024 following approval by the relevant competition authorities.공지 • Jan 16Lanxess Reportedly Seeks to Sell Polyurethane OpsLANXESS Aktiengesellschaft (XTRA:LXS) has initiated a process to sell its polyurethane business, which could be valued at between EUR 500 million (USD 547.2 million) and EUR 600 million, German paper Handelsblatt reported on January 15, 2024. The company has engaged Deutsche Bank to search for a buyer, Handelsblatt said, citing people familiar with the matter. Chemical companies such as Evonik Industries AG (XTRA:EVK), Stockmeier, or Plixxent, are considered possible interested parties. With the sale, Lanxess aims to completely exit the plastics market as the company has transformed into a producer of ingredients for food, cosmetics, and pharmaceuticals.Reported Earnings • Nov 08Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022)Third quarter 2023 results: €0.21 loss per share (down from €0.46 profit in 3Q 2022). Revenue: €3.77b (down 23% from 3Q 2022). Net loss: €96.0m (down 145% from profit in 3Q 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 11Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: €0.58 loss per share (down from €0.64 profit in 2Q 2022). Revenue: €3.89b (down 19% from 2Q 2022). Net loss: €270.0m (down 191% from profit in 2Q 2022). Revenue missed analyst estimates by 5.6%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.공지 • Aug 10+ 3 more updatesEvonik Industries AG to Report Q1, 2024 Results on May 08, 2024Evonik Industries AG announced that they will report Q1, 2024 results on May 08, 2024공지 • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).공지 • Jun 09RAG Stiftung Not in Hurry to Cut Evonik StakeRAG-Stiftung is not in a hurry to reduce its stake in chemicals firm Evonik Industries AG (XTRA:EVK) as the foundation is not under financial pressure, RAG chairman Bernd Toenjes said at a press conference as quotes by German paper Frankfurter Allgemeine Zeitung (FAZ). RAG Stiftung, which owns 54.9% in the chemicals company, plans to cut its stake to a blocking minority in the future. The shareholding may fall below the majority threshold soon. According to Toenjes, a convertible bond is due in 2024, providing an opportunity to reach 50% by the end of 2024. For the moment, Evonik remains one of the most important assets for RAG Stiftung.Upcoming Dividend • May 25Upcoming dividend of €1.17 per share at 5.9% yieldEligible shareholders must have bought the stock before 01 June 2023. Payment date: 05 June 2023. The company is paying out more than 100% of its profits and is paying out 81% of its cash flow. Trailing yield: 5.9%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.7%).Reported Earnings • May 10First quarter 2023 earnings released: EPS: €0.10 (vs €0.67 in 1Q 2022)First quarter 2023 results: EPS: €0.10 (down from €0.67 in 1Q 2022). Revenue: €4.01b (down 11% from 1Q 2022). Net income: €47.0m (down 85% from 1Q 2022). Profit margin: 1.2% (down from 7.0% in 1Q 2022). Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 03Full year 2022 earnings: EPS misses analyst expectationsFull year 2022 results: EPS: €1.16 (down from €1.61 in FY 2021). Revenue: €18.5b (up 24% from FY 2021). Net income: €539.0m (down 28% from FY 2021). Profit margin: 2.9% (down from 5.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 40%. Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 10Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: €0.46 (down from €0.49 in 3Q 2021). Revenue: €4.88b (up 26% from 3Q 2021). Net income: €214.0m (down 7.4% from 3Q 2021). Profit margin: 4.4% (down from 6.0% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 8.5%. Earnings per share (EPS) also surpassed analyst estimates by 5.1%. Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.공지 • Oct 12+ 2 more updatesEvonik Industries AG to Report Q2, 2023 Results on Aug 04, 2023Evonik Industries AG announced that they will report Q2, 2023 results on Aug 04, 2023Reported Earnings • Aug 11Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: €0.64 (up from €0.48 in 2Q 2021). Revenue: €4.77b (up 31% from 2Q 2021). Net income: €297.0m (up 34% from 2Q 2021). Profit margin: 6.2% (up from 6.1% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.7%. Earnings per share (EPS) also surpassed analyst estimates by 17%. Over the next year, revenue is expected to shrink by 1.9% compared to a 3.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Upcoming Dividend • May 19Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 26 May 2022. Payment date: 31 May 2022. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 4.5%. Within top quartile of German dividend payers (4.4%). Lower than average of industry peers (5.0%).Reported Earnings • May 07First quarter 2022 earnings: EPS exceeds analyst expectationsFirst quarter 2022 results: EPS: €0.67 (up from €0.41 in 1Q 2021). Revenue: €4.50b (up 34% from 1Q 2021). Net income: €314.0m (up 63% from 1Q 2021). Profit margin: 7.0% (up from 5.7% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 23%. Over the next year, revenue is forecast to grow 2.1%, compared to a 6.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 05Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: €1.61 (up from €1.05 in FY 2020). Revenue: €15.0b (up 23% from FY 2020). Net income: €748.0m (up 53% from FY 2020). Profit margin: 5.0% (up from 4.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) missed analyst estimates by 6.5%. Over the next year, revenue is forecast to grow 2.9%, compared to a 5.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 1% per year.공지 • Mar 04Evonik Industries AG to Report Q4, 2022 Results on Mar 02, 2023Evonik Industries AG announced that they will report Q4, 2022 results on Mar 02, 2023Reported Earnings • Nov 06Third quarter 2021 earnings released: EPS €0.49 (vs €0.32 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €3.87b (up 33% from 3Q 2020). Net income: €231.0m (up 55% from 3Q 2020). Profit margin: 6.0% (up from 5.1% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Reported Earnings • Aug 06Second quarter 2021 earnings released: EPS €0.48 (vs €0.26 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €3.64b (up 29% from 2Q 2020). Net income: €221.0m (up 77% from 2Q 2020). Profit margin: 6.1% (up from 4.4% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Upcoming Dividend • May 27Upcoming dividend of €1.15 per shareEligible shareholders must have bought the stock before 03 June 2021. Payment date: 08 June 2021. Trailing yield: 3.9%. Within top quartile of German dividend payers (3.2%). In line with average of industry peers (3.6%).Reported Earnings • May 08First quarter 2021 earnings released: EPS €0.41 (vs €0.29 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €3.36b (up 3.5% from 1Q 2020). Net income: €193.0m (up 42% from 1Q 2020). Profit margin: 5.7% (up from 4.2% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 05Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €12.2b (down 6.9% from FY 2019). Net income: €489.0m (down 35% from FY 2019). Profit margin: 4.0% (down from 5.7% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Mar 05Revenue beats expectations, earnings disappointRevenue exceeded analyst estimates by 0.3%. Earnings per share (EPS) missed analyst estimates by 14%. Over the next year, revenue is forecast to grow 5.8%, compared to a 5.4% growth forecast for the Chemicals industry in Germany.Is New 90 Day High Low • Feb 18New 90-day high: €27.99The company is up 18% from its price of €23.64 on 19 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €53.10 per share.Is New 90 Day High Low • Jan 29New 90-day high: €27.48The company is up 32% from its price of €20.82 on 30 October 2020. The German market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 29% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €53.29 per share.Is New 90 Day High Low • Jan 07New 90-day high: €27.31The company is up 17% from its price of €23.42 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €52.71 per share.Is New 90 Day High Low • Dec 16New 90-day high: €26.64The company is up 14% from its price of €23.29 on 17 September 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €44.77 per share.Is New 90 Day High Low • Nov 24New 90-day high: €25.02The company is up 1.0% from its price of €24.76 on 26 August 2020. The German market is also up 1.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.90 per share.Analyst Estimate Surprise Post Earnings • Nov 05Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 0.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.3%. Over the next year, revenue is forecast to grow 3.9%, compared to a 2.3% growth forecast for the Chemicals industry in Germany.Reported Earnings • Nov 05Third quarter 2020 earnings released: EPS €0.32The company reported a soft third quarter result with weaker earnings and revenues, although profit margins were improved. Third quarter 2020 results: Revenue: €2.92b (down 9.7% from 3Q 2019). Net income: €149.0m (down 2.6% from 3Q 2019). Profit margin: 5.1% (up from 4.7% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings.Is New 90 Day High Low • Oct 21New 90-day low: €21.91The company is down 12% from its price of €24.76 on 23 July 2020. The German market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €36.51 per share.Is New 90 Day High Low • Sep 24New 90-day low: €22.40The company is down 2.0% from its price of €22.95 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €36.43 per share.이익 및 매출 성장 예측DB:EVK - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202814,9335827671,631812/31/202714,5295057781,5711312/31/202614,4004137411,4721312/31/202514,0692656951,443N/A9/30/202514,265944561,269N/A6/30/202514,7074235131,325N/A3/31/202515,1382999411,720N/A12/31/202415,1572228731,713N/A9/30/202415,1632291,2161,978N/A6/30/202415,102-901,3282,072N/A3/31/202415,058-3569071,745N/A12/31/202315,267-4658011,594N/A9/30/202316,002-6048891,789N/A6/30/202317,109-2957081,675N/A3/31/202317,9952726731,568N/A12/31/202218,4885397851,650N/A9/30/202218,2389261741,100N/A6/30/202217,2319444101,284N/A3/31/202216,0958697501,630N/A12/31/202114,9557489291,815N/A9/30/202114,0787241,1962,086N/A6/30/202113,1246429841,920N/A3/31/202112,3145469701,924N/A12/31/202012,1994897711,727N/A9/30/202012,2706145731,482N/A6/30/202012,5856175071,403N/A3/31/202013,0656793701,259N/A12/31/201913,1087534411,321N/A9/30/201913,084506N/A1,517N/A6/30/201913,199624N/A1,619N/A3/31/201913,306673N/A1,826N/A12/31/201813,267686N/A1,760N/A9/30/201813,580841N/A1,708N/A6/30/201813,789797N/A1,877N/A3/31/201813,994788N/A1,567N/A12/31/201714,383713N/A1,551N/A9/30/201714,015723N/A1,667N/A6/30/201713,623718N/A1,449N/A3/31/201713,262656N/A1,708N/A12/31/201612,732748N/A1,769N/A9/30/201612,725758N/A1,774N/A6/30/201612,926725N/A1,982N/A3/31/201613,188981N/A1,863N/A12/31/201513,5071,008N/A1,971N/A9/30/201513,5351,027N/A1,776N/A6/30/201513,4131,004N/A1,373N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: EVK 의 연간 예상 수익 증가율(17.2%)이 saving rate(1.9%)보다 높습니다.수익 vs 시장: EVK 의 연간 수익(17.2%)이 German 시장(16.7%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: EVK 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: EVK 의 수익(연간 2%)이 German 시장(연간 6.4%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: EVK 의 수익(연간 2%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: EVK의 자본 수익률은 3년 후 8.8%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 07:18종가2026/05/07 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Evonik Industries AG는 30명의 분석가가 다루고 있습니다. 이 중 13명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Anil ShenoyBarclaysAndreas HeineBarclaysSebastian BrayBerenberg27명의 분석가 더 보기
공지 • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.
공지 • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).
공지 • Apr 17Evonik Industries AG, Annual General Meeting, Jun 03, 2026Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time.
공지 • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.
공지 • Nov 06+ 2 more updatesEvonik Industries AG to Report Q1, 2026 Results on May 08, 2026Evonik Industries AG announced that they will report Q1, 2026 results on May 08, 2026
공지 • Oct 06Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026
공지 • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.
공지 • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.
Reported Earnings • Nov 07Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: €0.48 (up from €0.21 loss in 3Q 2023). Revenue: €3.83b (up 1.6% from 3Q 2023). Net income: €223.0m (up €319.0m from 3Q 2023). Profit margin: 5.8% (up from net loss in 3Q 2023). Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
공지 • Sep 20Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025Evonik Industries AG announced that they will report Q1, 2025 results on May 12, 2025
공지 • Sep 04+ 1 more updateEvonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025Evonik Industries AG announced that they will report Q2, 2025 results on Aug 01, 2025
Reported Earnings • Aug 02Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023)Second quarter 2024 results: €0.01 loss per share (improved from €0.58 loss in 2Q 2023). Revenue: €3.93b (up 1.1% from 2Q 2023). Net loss: €5.00m (loss narrowed 98% from 2Q 2023). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • May 29Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.1%).
Reported Earnings • May 09First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023)First quarter 2024 results: EPS: €0.33 (up from €0.10 in 1Q 2023). Revenue: €3.80b (down 5.2% from 1Q 2023). Net income: €156.0m (up 232% from 1Q 2023). Profit margin: 4.1% (up from 1.2% in 1Q 2023). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance.
공지 • Apr 20+ 1 more updateEvonik Industries AG, Annual General Meeting, May 28, 2025Evonik Industries AG, Annual General Meeting, May 28, 2025.
Reported Earnings • Mar 05Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: €1.00 loss per share (down from €1.16 profit in FY 2022). Revenue: €15.3b (down 17% from FY 2022). Net loss: €465.0m (down 186% from profit in FY 2022). Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) also missed analyst estimates by 42%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
공지 • Mar 05International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik.International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik on March 4, 2024. The business to be sold generated sales of €892 million in 2023, with adjusted EBITDA in the mid double-digit million euro range. The final transfer of the business is planned for mid-2024 following approval by the relevant competition authorities.
공지 • Jan 16Lanxess Reportedly Seeks to Sell Polyurethane OpsLANXESS Aktiengesellschaft (XTRA:LXS) has initiated a process to sell its polyurethane business, which could be valued at between EUR 500 million (USD 547.2 million) and EUR 600 million, German paper Handelsblatt reported on January 15, 2024. The company has engaged Deutsche Bank to search for a buyer, Handelsblatt said, citing people familiar with the matter. Chemical companies such as Evonik Industries AG (XTRA:EVK), Stockmeier, or Plixxent, are considered possible interested parties. With the sale, Lanxess aims to completely exit the plastics market as the company has transformed into a producer of ingredients for food, cosmetics, and pharmaceuticals.
Reported Earnings • Nov 08Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022)Third quarter 2023 results: €0.21 loss per share (down from €0.46 profit in 3Q 2022). Revenue: €3.77b (down 23% from 3Q 2022). Net loss: €96.0m (down 145% from profit in 3Q 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 11Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: €0.58 loss per share (down from €0.64 profit in 2Q 2022). Revenue: €3.89b (down 19% from 2Q 2022). Net loss: €270.0m (down 191% from profit in 2Q 2022). Revenue missed analyst estimates by 5.6%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
공지 • Aug 10+ 3 more updatesEvonik Industries AG to Report Q1, 2024 Results on May 08, 2024Evonik Industries AG announced that they will report Q1, 2024 results on May 08, 2024
공지 • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).
공지 • Jun 09RAG Stiftung Not in Hurry to Cut Evonik StakeRAG-Stiftung is not in a hurry to reduce its stake in chemicals firm Evonik Industries AG (XTRA:EVK) as the foundation is not under financial pressure, RAG chairman Bernd Toenjes said at a press conference as quotes by German paper Frankfurter Allgemeine Zeitung (FAZ). RAG Stiftung, which owns 54.9% in the chemicals company, plans to cut its stake to a blocking minority in the future. The shareholding may fall below the majority threshold soon. According to Toenjes, a convertible bond is due in 2024, providing an opportunity to reach 50% by the end of 2024. For the moment, Evonik remains one of the most important assets for RAG Stiftung.
Upcoming Dividend • May 25Upcoming dividend of €1.17 per share at 5.9% yieldEligible shareholders must have bought the stock before 01 June 2023. Payment date: 05 June 2023. The company is paying out more than 100% of its profits and is paying out 81% of its cash flow. Trailing yield: 5.9%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.7%).
Reported Earnings • May 10First quarter 2023 earnings released: EPS: €0.10 (vs €0.67 in 1Q 2022)First quarter 2023 results: EPS: €0.10 (down from €0.67 in 1Q 2022). Revenue: €4.01b (down 11% from 1Q 2022). Net income: €47.0m (down 85% from 1Q 2022). Profit margin: 1.2% (down from 7.0% in 1Q 2022). Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 03Full year 2022 earnings: EPS misses analyst expectationsFull year 2022 results: EPS: €1.16 (down from €1.61 in FY 2021). Revenue: €18.5b (up 24% from FY 2021). Net income: €539.0m (down 28% from FY 2021). Profit margin: 2.9% (down from 5.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 40%. Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 10Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: €0.46 (down from €0.49 in 3Q 2021). Revenue: €4.88b (up 26% from 3Q 2021). Net income: €214.0m (down 7.4% from 3Q 2021). Profit margin: 4.4% (down from 6.0% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 8.5%. Earnings per share (EPS) also surpassed analyst estimates by 5.1%. Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
공지 • Oct 12+ 2 more updatesEvonik Industries AG to Report Q2, 2023 Results on Aug 04, 2023Evonik Industries AG announced that they will report Q2, 2023 results on Aug 04, 2023
Reported Earnings • Aug 11Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: €0.64 (up from €0.48 in 2Q 2021). Revenue: €4.77b (up 31% from 2Q 2021). Net income: €297.0m (up 34% from 2Q 2021). Profit margin: 6.2% (up from 6.1% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.7%. Earnings per share (EPS) also surpassed analyst estimates by 17%. Over the next year, revenue is expected to shrink by 1.9% compared to a 3.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Upcoming Dividend • May 19Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 26 May 2022. Payment date: 31 May 2022. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 4.5%. Within top quartile of German dividend payers (4.4%). Lower than average of industry peers (5.0%).
Reported Earnings • May 07First quarter 2022 earnings: EPS exceeds analyst expectationsFirst quarter 2022 results: EPS: €0.67 (up from €0.41 in 1Q 2021). Revenue: €4.50b (up 34% from 1Q 2021). Net income: €314.0m (up 63% from 1Q 2021). Profit margin: 7.0% (up from 5.7% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 23%. Over the next year, revenue is forecast to grow 2.1%, compared to a 6.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 05Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: €1.61 (up from €1.05 in FY 2020). Revenue: €15.0b (up 23% from FY 2020). Net income: €748.0m (up 53% from FY 2020). Profit margin: 5.0% (up from 4.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) missed analyst estimates by 6.5%. Over the next year, revenue is forecast to grow 2.9%, compared to a 5.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 1% per year.
공지 • Mar 04Evonik Industries AG to Report Q4, 2022 Results on Mar 02, 2023Evonik Industries AG announced that they will report Q4, 2022 results on Mar 02, 2023
Reported Earnings • Nov 06Third quarter 2021 earnings released: EPS €0.49 (vs €0.32 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €3.87b (up 33% from 3Q 2020). Net income: €231.0m (up 55% from 3Q 2020). Profit margin: 6.0% (up from 5.1% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 06Second quarter 2021 earnings released: EPS €0.48 (vs €0.26 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €3.64b (up 29% from 2Q 2020). Net income: €221.0m (up 77% from 2Q 2020). Profit margin: 6.1% (up from 4.4% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • May 27Upcoming dividend of €1.15 per shareEligible shareholders must have bought the stock before 03 June 2021. Payment date: 08 June 2021. Trailing yield: 3.9%. Within top quartile of German dividend payers (3.2%). In line with average of industry peers (3.6%).
Reported Earnings • May 08First quarter 2021 earnings released: EPS €0.41 (vs €0.29 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €3.36b (up 3.5% from 1Q 2020). Net income: €193.0m (up 42% from 1Q 2020). Profit margin: 5.7% (up from 4.2% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 05Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €12.2b (down 6.9% from FY 2019). Net income: €489.0m (down 35% from FY 2019). Profit margin: 4.0% (down from 5.7% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Mar 05Revenue beats expectations, earnings disappointRevenue exceeded analyst estimates by 0.3%. Earnings per share (EPS) missed analyst estimates by 14%. Over the next year, revenue is forecast to grow 5.8%, compared to a 5.4% growth forecast for the Chemicals industry in Germany.
Is New 90 Day High Low • Feb 18New 90-day high: €27.99The company is up 18% from its price of €23.64 on 19 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €53.10 per share.
Is New 90 Day High Low • Jan 29New 90-day high: €27.48The company is up 32% from its price of €20.82 on 30 October 2020. The German market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 29% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €53.29 per share.
Is New 90 Day High Low • Jan 07New 90-day high: €27.31The company is up 17% from its price of €23.42 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €52.71 per share.
Is New 90 Day High Low • Dec 16New 90-day high: €26.64The company is up 14% from its price of €23.29 on 17 September 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €44.77 per share.
Is New 90 Day High Low • Nov 24New 90-day high: €25.02The company is up 1.0% from its price of €24.76 on 26 August 2020. The German market is also up 1.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.90 per share.
Analyst Estimate Surprise Post Earnings • Nov 05Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 0.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.3%. Over the next year, revenue is forecast to grow 3.9%, compared to a 2.3% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Nov 05Third quarter 2020 earnings released: EPS €0.32The company reported a soft third quarter result with weaker earnings and revenues, although profit margins were improved. Third quarter 2020 results: Revenue: €2.92b (down 9.7% from 3Q 2019). Net income: €149.0m (down 2.6% from 3Q 2019). Profit margin: 5.1% (up from 4.7% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings.
Is New 90 Day High Low • Oct 21New 90-day low: €21.91The company is down 12% from its price of €24.76 on 23 July 2020. The German market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €36.51 per share.
Is New 90 Day High Low • Sep 24New 90-day low: €22.40The company is down 2.0% from its price of €22.95 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €36.43 per share.